Verastem directors buy $475K of stock, company set for potential pivotal trials

Business News Jun 13 2013 BoardNews

Three directors of cancer drug company Verastem Inc. and its founding executive chairman have purchased $475,000 worth of the company’s stock in the past week as it plans to start a potential pivotal trial against mesothelioma in coming months.

Read Full Article

Bookmark or Share this article

Login to comment.

Corporate Boards: Shifting From Aging Men To New Generation Of Women? also categorized in BoardNews
Taiwan Court Orders Reinstatement Of Two CPDC Board Candidates As Contested Vote Nears also categorized in BoardNews
Six Years Later, The Problem at HP is Still the Board also categorized in BoardNews
Agios Scores Biogen CFO as Board Member also written by Don Seiffert
New Baxter CEO Steps Down From EMC Board also published in Business News
Getting Gen-Y on Boards (of Directors) also categorized in BoardNews
Germany's Corporate Governance Problem also categorized in BoardNews
20 Taiwan Businesspeople To Watch -- James Kuo, Austin Liu and Andy Lu also categorized in BoardNews
Netflix: Icahn Says Poison Pill 'Poor Corporate Governance' also categorized in BoardNews
Care.com Shutting Down e-Commerce Firm it Previously Acquired, Loses Board Member also published in Business News

Verastem directors buy $475K of stock, company set for potential pivotal trials

Login to comment.

Related Articles

Topics Mentioned

Authors

Verastem directors buy $475K of stock, company set for potential pivotal trials

Login to comment.

Related Articles

Categories

BoardProspects Features:

Topics Mentioned

Authors